» Articles » PMID: 6305632

Receptor-mediated Mitogenic Action of Prolactin in a Rat Lymphoma Cell Line

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1983 Jul 1
PMID 6305632
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

PRL and other lactogenic hormones are potent mitogens in a lymphoma cell line derived from a lymph node of an estrogenized Noble (Nb) rat. The present study demonstrates that these cells (designated Nb2 node) possess receptors that bind only lactogenic hormones. There are approximately 12,000 receptor sites per cell. The kinetics of binding of [125I]iodo-PRL exhibited by Nb2 lymphoma cells is unusual in that PRL binding follows a biphasic pattern. Binding of [125I]iodo-PRL reaches a maximum in 1 h at 37 C, followed by a rapid decline. This pattern was not observed if binding was carried out in the presence of chloroquine, a lysosomotropic agent, or if cell homogenate was used for binding. We also examined the relationship between receptor occupancy and the magnitude of PRL response in these cells. Maximal growth stimulation by PRL occurs when only 35% of the maximal binding of PRL is achieved, suggesting that a majority of the PRL binding sites may be spare receptors. This study also revealed that the dissociation constant (Kd) of the PRL receptors in Nb2 cells is 75 pM, approximately 20-fold higher than that of the receptors in other cell types. PRL at 6 pM produces a half-maximal growth response in the Nb2 cells. Antibodies against the PRL receptors are able to abolish the PRL-induced proliferation of Nb2 cells. In the absence of PRL, these antibodies alone can induce proliferation of Nb2 cells, mimicking the action of PRL. Divalent (Fab)2 fragments, but not monovalent Fab, were also effective. These observations suggest that antibodies to the receptor, or the hormone itself, initiate a biological response possibly by cross-linking PRL receptors on the cell membrane, and that the entry of the PRL molecule, or fragments of it, into the intracellular compartment is not necessary for the biological action of PRL.

Citing Articles

Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis.

Yun S, Sang H, Park S, Chin S Int J Mol Sci. 2024; 25(3).

PMID: 38338751 PMC: 10855748. DOI: 10.3390/ijms25031474.


The role of prolactin in the pathogenesis of autoimmune disease.

Berczi I Endocr Pathol. 2020; 4(4):178-195.

PMID: 32138433 DOI: 10.1007/BF02915460.


The forgotten lactogenic activity of growth hormone: important implications for rodent studies.

Bartke A, Kopchick J Endocrinology. 2015; 156(5):1620-2.

PMID: 25730109 PMC: 4398757. DOI: 10.1210/en.2015-1097.


Prolactin induces apoptosis of lactotropes in female rodents.

Ferraris J, Zarate S, Jaita G, Boutillon F, Bernadet M, Auffret J PLoS One. 2014; 9(5):e97383.

PMID: 24859278 PMC: 4032245. DOI: 10.1371/journal.pone.0097383.


Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.

Rose-Hellekant T, Arendt L, Schroeder M, Gilchrist K, Sandgren E, Schuler L Oncogene. 2003; 22(30):4664-74.

PMID: 12879011 PMC: 1630768. DOI: 10.1038/sj.onc.1206619.